Business ❯ Corporate Governance ❯ Investor Relations ❯ Financial Reporting

Market Performance

Boston Scientific Investors Urged to Seek Lead Plaintiff Role in Securities Suit

The outreach highlights claims that Boston Scientific overstated the health of its U.S. electrophysiology business.

BellRing Securities Class Action Pushes Forward in SDNY as Firms Rally Investors Before March 23 Deadline

James Hardie Investors Face Dec. 23 Deadline To Seek Lead Role in Securities Class Action